PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PHOSPHORUS METABOLISM”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 649 records · Page 36Linked to original sources

[News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].

Bone metabolism is very frequently disturbed in end stage renal failure hemodialyzed, with secondary hyperparathyroidism development but also serious potential cardiovascular consequences. New treatments will be available very soon in Europe such as new phosphate binders, vitamin D2 analogues or calcimimetics to fight against such medical diseases, with the hope of less risk for vascular complications. The real place of such new medical opportunities needs to be determined. Moreover, studies with morbidity and mortality end-points are waited before estimating the real importance of these new therapeutic tools.

Calcium↗

Renal regulation of avian calcium and phosphorus metabolism.

Avian plasma calcium (Ca) and inorganic phosphate (Pi) concentrations are coregulated by parathyroid hormone (PTH) and vitamin D acting directly or indirectly on the intestine, bone and kidneys. Within the overall scheme of chemical, hormonal and target tissue interactions, the kidneys serve as a safety valve, operating on a minute-to-minute basis to excrete Ca and Pi when these minerals are present in excess or to conserve Ca and Pi when they are needed for eggshell formation or bone mineral replenishment. This key role of the kidneys is directly mediated by PTH, acting to stimulate Ca reabsorption and increase Pi excretion at the tubular level. By dissociating Ca from Pi transport, the kidneys serve to maintain appropriate blood Ca:Pi concentration ratios during extremes of dietary challenge or bone mineral mobilization. Direct regulatory roles for vitamin D metabolites and calcitonin on avian urinary Ca and Pi excretion have yet to be firmly established.

Animals↗

Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry.

Histomorphometric analysis of iliac crest biopsies was performed after tetracycline double-labelling in 22 hyperthyroid patients before and after medical antithyroid treatment for an average period of 4 months. The initially increased cortical porosity was normalized during treatment whereas the amount of trabecular bone was unchanged. The osteoclastic resorption in cortical bone decreased but was still elevated. The osteocytic osteolysis remained slightly increased. In trabecular bone, however, the bone turn-over decreased to a subnormal level following treatment and the surfaces were inactive in bone resorption and bone formation. An increase was observed in the amount, extent and width of osteoid seams due to an increase in the lifespan of bone forming sites and a prolongation of the maturity period of osteoid. The observed increased deposition of cortical bone after antithyroid treatment may explain the positive calcium balance in this period.

Adult↗

[Calcium-phosphorus metabolism and calcitrophic hormones in patients with active acromegaly with and without osteoporosis].

Calcium-phosphor metabolism was studied in patients with active acromegaly with or without osteoporosis, mean age 45.2 +/- 11.4 years and mean duration of the basic disease 5.52 +/- 3.6 years. No significant deviations and no direct relation with the high serum growth hormone and prolactin levels were found. The normal basic secretion of the calcitrophic hormones--parathyroid hormone and calcitonin and their normal response to the hypercalcemia after intravenous calcium load of the patients with and without osteoporosis reject their direct participation in the pathogenesis of osteopenia. The changed skeletal sensitivity to calcitrophic hormones closely connected with the patients' age and the duration of the basic disease in combination with many other factors probably plays a major role in the pathogenesis of osteopenia.

Acromegaly↗

Combining solid-state and solution-state 31P NMR to study in vivo phosphorus metabolism.

Otherwise unavailable information concerning the distribution of phosphorylated compounds in biological systems is obtained by a combined solid-state/solution-state NMR approach, illustrated here for oocytes from Rana pipiens. General methodology is developed, and further extensions are proposed. The following conclusions pertain to the specific system under examination. (i) Nucleoside phosphates can be observed by magic-angle sample spinning of the lyophilized material. (ii) The solid-state NMR technique of dipolar decoupling provides no additional resolution of the phospholipid and phosphoprotein components of the yolk. However, cellular death produces sufficient pH changes to cause the phospholipid and protein phosphate peaks to become resolvable. The concentration of nucleoside phosphates also decreases. (iii) The phospholipid and phosphoprotein components are shown by computer simulation to be present in a ratio of 40:60, respectively. (iv) The amounts of inorganic phosphate, nucleoside phosphates, and sugar phosphates are determined by solution-state NMR observation of the perchloric acid extract of the oocytes.

Animals↗

Frontal lobe phosphorus metabolism and neuropsychological function in aging and in Alzheimer's disease.

31P Magnetic resonance spectroscopy of the frontal lobe was performed in 17 patients with Alzheimer's disease (AD), 8 elderly controls (EC), and 17 young controls (YC). The phosphocreatine/inorganic phosphate (PCr/Pi) ratio in AD (2.32 +/- 0.26 SD) was significantly lower than in EC (2.65 +/- 0.41). In AD patients, a correlation was observed between the PCr/Pi ratio and the dementia rating scale (r = -0.50, p = 0.04). A significant positive correlation between PCr/Pi ratio and age was observed in both AD (r = 0.67, p = 0.003) and YC (r = 0.63, p = 0.006) groups, however, suggesting caution in interpretation of this ratio in AD. We did not find differences between AD, EC, or YC in any other spectroscopic measure. A significant sex difference in the phosphomonoester/phosphodiester ratio (PME/PDE) ratio was observed in AD brain. Females had a lower PME/PDE ratio than males.

Adult↗

Vanadium as a factor that disturbs phosphorus metabolism in nervous tissue.

Vanadium and its derivatives are the well-known environmental pollutants. We obtained that ammonium vanadate suppressed the alkaline (AlP) and acid (AcP) phosphatases activity in the variety of tissues. Vanadate inhibited the enzymes that take part in phosphoryl transfer reactions. Successive concentration-dependent decrease in AlP and AcP activities by vanadate (0.1 mM-1 mM) has been obtained in rat nervous tissue. Moreover, the observed reduction in the sensitivity of the enzymes to vanadate ions becomes more pronounced at the transition from higher and relatively young regions of nervous system to its more ancient parts. Phosphoprotein phosphatase (PP) activity has also been inhibited in various structures of brain tissue; in spinal cord, however, vanadate in comparatively low concentrations (10 microM) caused a steep rise in the enzyme activity. Only at high concentration (1 mM) vanadate exert the effect of moderate inhibition. The possibility of the existence of phylogenetically different molecular forms of nervous tissue PPs differed by their sensitivity to vanadate was supported in our comparative examination.

Acid Phosphatase↗

The relationship between serum 25-hydroxy-vitamin D levels and other variables related to calcium and phosphorus metabolism in the elderly.

Three groups of elderly people (65-80 years) were studied with regard to their vitamin D status: group 1 (G1), long-stay geriatric patients; group 2 (G2), residents of an old people's home; group 3 (G3), elderly people living in their own homes. Young adults (35-50 years) served as controls (C). The 25-OH-D was significantly lower in G1 (17 +/- 7 nmol/l) than in G2 (38 +/- 14), G3 (64 +/- 23) and C (70 +/- 21), (mean +/- SD). The concentration in G2 was significantly lower than in G3 and C. The corrected s-Ca concentration was significantly lower in G1 (2.30 +/- 0.17 mmol/l) than in any of the other groups (G2: 2.47 +/- 0.11; G3: 2.44 +/- 0.10; C: 2.39 +/- 0.09 mmol/l). The s-ALP activity was significantly higher in all groups of elderly people (G1: 155 +/- 43 U/l; G2: 161 +/- 61; G3: 143 +/- 41) than in C (104 +/- 22). The s-Pi concentration was significantly lower in C (1.16 +/- 0.14 mmol/l) than in the elderly (G1: 1.43 +/- 0.37; G2: 1.30 +/- 0.19; G3: 1.28 +/- 0.13). The PTH concentrations in some of G1 (0.68 +/- 1.14 micrograms/l) and G2 (0.47 +/- 0.41) were higher than in some of G3 (0.30 +/- 0.05) and C (0.23 +/- 0.07); the difference was not significant. There was a significant negative correlation between the inverse of the 25-OH-D and the s-Ca and the 25-OH-D and s-ALP.(ABSTRACT TRUNCATED AT 250 WORDS)

Age Factors↗

Calcium and phosphorus metabolism and eggshell formation of hens fed different amounts of calcium.

Twenty-seven 42-wk-old Single Comb White Leghorn hens housed in separate cages were fed either 2.5, 3.5, or 4.5% Ca diets, each providing .45% available P. Birds were allowed a 7-day adaption period followed by an 8-day collection period. Feed and water were available for ad libitum consumption with feed intake recorded daily. Eggs and excreta were collected daily for mineral analysis. Feed, Ca, and P intake of hens increased significantly (P less than .05) on shell-forming (SF) days compared with days on which shell formation did not take place (NSF). Dietary Ca level had a significant (P less than .05) effect on feed and Ca intake of hens. On SF days, hens retained more dietary Ca, both as a percentage and per gram Ca basis, compared with NSF days. As dietary Ca increased, the percentage Ca retained decreased (P less than .05) and per gram Ca retained increased (P less than .05). Dietary Ca had no effect (P greater than .05) on egg weight or egg production. Increasing dietary Ca significantly (P less than .05) decreased shell deformation and increased (P less than .05) shell weight and grams of shell Ca, although there was no significant (P greater than .05) effect on percentage shell Ca. Calcium retention increased linearly (P less than .05) as Ca intake increased, and shell weight increased quadratically (P less than .05). There was a diminishing response of shell weight to Ca intake at higher levels.

Animals↗

31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumor growth and treatment with cisplatin on the tumor phosphorus metabolism, histology and cytokinetics.

A xenografted hypopharynx carcinoma growing subcutaneously in nude mice was studied by in vivo 31P NMR spectroscopy during uninfluenced growth and following treatment with cisplatin (CDDP). Parallel to the NMR experiments, the cytokinetic and histological changes in the tumor were investigated. The most significant change in the growing tumor was a decline in the level of phosphocreatine (PCr), whereas the tumor pH did not change. Following treatment with CDDP (4, 8 and 12 mg/kg), a dose-dependent decrease in the level of phosphomonoesters (PME) took place, whilst no dose dependence could be observed for the increase of PCr. the pH shifted to alkaline only after administration of the highest CDDP dose. Tumor cytokinetics revealed a cell arrest at the G1/S boundary 24 h after chemotherapy. At this time, the histological sections showed a dilatation of capillaries, whereas first necroses appeared on day 3. The proliferative activity of the tumor showed a sharp decline 24 h after CDDP application, followed by a revival of cell proliferation that was proportional to the dose applied between days 5 and 7. This increase in proliferative activity was paralleled by a marked increase in the PME/phosphodiesters ratio. Thus, in the tumor investigated the PME were the best indicators of tumor response to therapy. A precise correlation between the cytokinetic data and the re-energization of the tumor was not possible because histological changes, which may contribute to improved tumor energy status took place at the same time.

Animals↗

Effect of intermittent exposure to 3% CO2 on respiration, acid-base balance, and calcium-phosphorus metabolism.

One subject was exposed for six days to increasing levels of CO2, rising at a constant rate from 0.03 to 3.0% CO2 within a 15-h period followed by 9 h of air breathing. To assess acid-base parameters, arterialized capillary blood was taken from a finger twice daily (at 8 a.m. and 11 p.m.) at times corresponding to the beginning and end of the intermittent exposure to CO2. Venous blood samples were obtained on alternate days at the same times. Urine specimens were collected twice daily. The subject was on a liquid diet. Resting respiratory minute volume (VE), oxygen consumption (VO2), carbon dioxide excretion (VCO2), alveolar carbon dioxide and oxygen tension (PACO2) and PAO2) were measured twice daily. PACO2 and PAO2 were also determined at the end of breath-holding twice daily; CO2 tolerance tests and lung function tests were also carried out. In contrast to the effects of chronic exposure to 3% CO2, the CO2 tolerance tests showed an increased sensitivity (increase of slope) and breath-holding PACO2 did not change, indicating that acclimatization to CO2 did not develop. The ventilatory response to CO2 was not sufficient to prevent CO2 accumulation in the body; this accumulation was eliminated during the nightly air-breathing periods on the fourth and fifth days, indicated by higher values of PaCO2 and PACO2. The known renal response to hypercapnia, consisting of an increased excretion of titratable acidity, ammonia, and hydrogen ion excretion, occurred but was interrupted after the first day and was triggered again on the fourth and fith days when accumulated CO2 was released from body CO2 stores. The second renal response was associated with a marked calcium excretion, which suggests that bone CO2 stores were involved.

Acid-Base Equilibrium↗

Calcium and phosphorus metabolism and eggshell thickness in laying hens producing thick or thin shells.

Two experiments were carried out to investigate the Ca and P metabolism of hens laying thick- (THK) or thin-shelled (THN) eggs on shell-forming days (SF) and days on which shell formation does not occur (NSF). In Experiment 1, 10 hens identified as producing THK or 10 hens producing THN eggs were offered a diet containing 3.5% Ca and .4% available P. Feed consumption, egg production, egg weight, egg deformation, and shell weight were recorded over 8 days. Shells and excreta were collected daily for Ca and P analysis. Feed, Ca, and P intake did not differ significantly (P greater than 0.5) between the two groups of hens, however, feed intake and Ca retention increased significantly (P less than .05) on SF compared with NSF days. The THK hens retained significantly (P less than .05) more Ca compared with THN hens. No differences (P greater than .05) were recorded for egg production, although there were differences (P less than .05) in egg weight and shell deformation between the two groups of hens. Increased egg weight did not account for differences (P less than .05) in eggshell deformation. Although percentage shell Ca was not significantly different (P greater than .05), total shell Ca was different (P less than .05) between the two groups. In Experiment 2, both groups of birds (THK and THN) were allowed simultaneous access to two different diets, a high-energy, high-protein diet low in Ca and P, and a low-energy, low-protein diet high in Ca and P.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Effect of dietary aluminum sulfate on calcium and phosphorus metabolism of broiler chicks.

The effect of dietary aluminum sulfate on Ca and P metabolism was studied using 1-day-old male broiler chicks. In Experiment 1, practical diets providing .90% Ca plus .45% available P (Pav), .90% Ca plus .78% Pav, 1.80% Ca plus .45% Pav, or 1.80% Ca plus .90% Pav were fed with 0 or .392% A1 as aluminum sulfate for 21 days. The control diet (.90% Ca plus .45% Pav) without added A1 was fed to all chicks during Days 22 to 49. In general, A1 significantly (P less than .05) decreased BW gain, feed intake, gain:feed ratio, plasma inorganic P (Pi), tibia breaking strength, tibia weight, percentage of tibia ash, and plasma Zn, measured at Day 21. Elevating Pav increased BW gain, feed intake, gain:feed ratio, tibia weight and plasma Zn, and decreased plasma total Ca in the presence of .392% A1 plus 1.80% Ca. Plasma Pi, tibia breaking strength, and percentage of tibia ash were increased by raising dietary Pav in the presence of .392% A1 with either level of Ca. Negative effects of dietary A1 on feed intake and BW persisted through Day 49. In Experiment 2, a control diet (.90% Ca, .45% Pav) was fed for ad libitum access either alone or supplemented with .2% A1 as aluminum sulfate or with an equivalent amount of sulfate provided by potassium sulfate. The control diet was also pair-fed to chicks given .2% A1. Dietary A1 significantly depressed weight gain, feed intake, gain:feed ratio, and plasma Pi.(ABSTRACT TRUNCATED AT 250 WORDS)

Alum Compounds↗

Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.

Humoral hypercalcemia of malignancy (HHM) is at least partly caused by tumor secretion of PTH-related peptide (PTHrP), but there is growing evidence for cosecretion with PTHrP of other bone-resorbing peptides, such as the cytokine interleukin-1 alpha (IL-1 alpha). Administration of PTHrP in vivo and in vitro generally mimics the actions of PTH itself, with increases in both resorption and formation of bone. However, bone in HHM is characterized by uncoupling of bone turnover, with increased resorption and decreased formation. We performed experiments to determine whether IL-1 alpha might alter the effects of PTHrP and produce uncoupling. Thus, we administered to 100-g male rats by sc osmotic minipumps synthetic PTHrP-(1-34) alone (2 micrograms/100 g/day), recombinant IL-1 alpha alone (1.5 micrograms/100 g/day), both peptides together at the previous doses, or vehicle only. We infused 5 groups of 12 rats each (PTHrP, IL-1 alpha, PTHrP plus IL-1 alpha, ad libitum fed control, and controls pair-fed to the PTHrP plus IL-1 alpha group) for 14 days. At the end of the study, blood and urine were taken for chemical measurements, and tibias and femurs were harvested for histomorphometry and extraction of RNA from periosteal cells. As expected, PTHrP induced hypercalcemia, relative hypophosphatemia, phosphaturia, and reduced bone mass. Osteoblast number was increased, but osteoclast number was not. Indices of bone formation were unchanged or reduced. The dose of IL-1 alpha chosen had no statistically significant effect, except for reduced longitudinal bone growth, but when combined with PTHrP, IL-1 alpha reduced hypercalcemia, hypophosphatemia, and phosphaturia. In contrast to the blood and urine effects, IL-1 alpha did not interact significantly with PTHrP's effect on bone measurements. Northern analysis of periosteal cell mRNA showed that PTHrP reduced expression of osteocalcin, but not glyceraldehyde-3-phosphate dehydrogenase; IL-1 alpha had no additional effect. These data suggest that 1) continuously administered PTHrP alone may induce uncoupled bone turnover with decreased cortical bone formation; 2) IL-1 alpha appears to inhibit strongly the renal effects of PTHrP and weakly (if at all) its actions on bone and, thus, to decrease its hypercalcemic, phosphaturic, and hypophosphatemic actions; and 3) cosecretion of IL-1 alpha, and possibly other peptide cytokines, with PTHrP may modify the clinical expression of HHM.

Animals↗